CH629490A5 - Processes for preparing the novel N,N'-bis-(3-methylthiazolidin-2-ylidene)succinamide. - Google Patents

Processes for preparing the novel N,N'-bis-(3-methylthiazolidin-2-ylidene)succinamide. Download PDF

Info

Publication number
CH629490A5
CH629490A5 CH518177A CH518177A CH629490A5 CH 629490 A5 CH629490 A5 CH 629490A5 CH 518177 A CH518177 A CH 518177A CH 518177 A CH518177 A CH 518177A CH 629490 A5 CH629490 A5 CH 629490A5
Authority
CH
Switzerland
Prior art keywords
compound
formula
alkyl
bis
salts
Prior art date
Application number
CH518177A
Other languages
German (de)
English (en)
Inventor
Clarence Stanley Rooney
Joshua Rokach
Edward Jethro Jun Cragoe
George Gal
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of CH629490A5 publication Critical patent/CH629490A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/18—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/39—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups
    • C07C205/42—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups having nitro groups or esterified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C205/43—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups having nitro groups or esterified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/16—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CH518177A 1976-05-03 1977-04-26 Processes for preparing the novel N,N'-bis-(3-methylthiazolidin-2-ylidene)succinamide. CH629490A5 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68287676A 1976-05-03 1976-05-03

Publications (1)

Publication Number Publication Date
CH629490A5 true CH629490A5 (en) 1982-04-30

Family

ID=24741558

Family Applications (1)

Application Number Title Priority Date Filing Date
CH518177A CH629490A5 (en) 1976-05-03 1977-04-26 Processes for preparing the novel N,N'-bis-(3-methylthiazolidin-2-ylidene)succinamide.

Country Status (24)

Country Link
JP (1) JPS52133981A (da)
AU (1) AU508889B2 (da)
BE (1) BE854172A (da)
CA (1) CA1078846A (da)
CH (1) CH629490A5 (da)
DE (1) DE2719577A1 (da)
DK (1) DK173777A (da)
ES (2) ES458237A1 (da)
FI (1) FI771285A (da)
FR (1) FR2350351A1 (da)
GB (1) GB1534242A (da)
HU (1) HU180504B (da)
IE (1) IE46011B1 (da)
IL (1) IL51935A (da)
IT (1) IT1082657B (da)
LU (1) LU77243A1 (da)
NL (1) NL7704322A (da)
NO (1) NO146061C (da)
NZ (1) NZ183941A (da)
PH (1) PH14030A (da)
PL (1) PL123449B1 (da)
SE (1) SE7704594L (da)
YU (1) YU111677A (da)
ZA (1) ZA772614B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU188852B (en) * 1983-03-16 1986-05-28 Richter Gedeon Vegyeszeti Gyar Rt,Hu Process for producing thiazolidine derivatives active against gastric ulcer and intestinal ulcer
US5555162A (en) * 1994-04-26 1996-09-10 Sylvan R. Shemitz Designs, Inc. Compact fluorescent luminaire
USRE37310E1 (en) 1994-12-06 2001-08-07 Sylvan R. Shemitz Designs, Inc. Compact fluorescent luminaire
FR2748023B1 (fr) 1996-04-30 1998-07-24 Rhone Poulenc Chimie Hydrogenofluorosulfonates de base organique, leur utilisation pour liberer les bases organiques de leur fluorhydrate, leur procede de preparation, compositions les comportant

Also Published As

Publication number Publication date
NO146061B (no) 1982-04-13
BE854172A (fr) 1977-11-03
HU180504B (en) 1983-03-28
ES458237A1 (es) 1978-07-01
CA1078846A (en) 1980-06-03
NO771375L (no) 1977-11-04
PL123449B1 (en) 1982-10-30
FR2350351B1 (da) 1979-03-02
IL51935A (en) 1981-07-31
IE46011B1 (en) 1983-01-26
PH14030A (en) 1980-12-12
ZA772614B (en) 1978-12-27
NL7704322A (nl) 1977-11-07
NO146061C (no) 1982-07-28
JPS52133981A (en) 1977-11-09
AU508889B2 (en) 1980-04-03
NZ183941A (en) 1980-12-19
FI771285A (da) 1977-11-04
ES468377A1 (es) 1978-12-16
IL51935A0 (en) 1977-06-30
DK173777A (da) 1977-11-04
IE46011L (en) 1977-11-03
LU77243A1 (da) 1977-12-13
SE7704594L (sv) 1977-11-04
YU111677A (en) 1983-01-21
DE2719577A1 (de) 1977-11-24
AU2463077A (en) 1978-11-02
FR2350351A1 (fr) 1977-12-02
IT1082657B (it) 1985-05-21
GB1534242A (en) 1978-11-29

Similar Documents

Publication Publication Date Title
DE2824064A1 (de) Phthalazin-derivate, ihre herstellung und solche derivate enthaltende arzneimittel
DE69023928T2 (de) DIAMINVERBINDUNGEN UND ARZNEIMITTEL GEGEN CEREBRALE STöRUNGEN DIE DIESE ENTHALTEN.
DE2065636A1 (de) Neue tricyclische verbindungen
DE3125471C2 (de) Piperazinderivate, Verfahren zu ihrer Herstellung und Arzneimittel, die diese Verbindungen enthalten
EP1529041B1 (de) Neue prodrugs von 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carbonsäure-(n -2-pyridil-n-2-hydroxycarbonylethyl)-amid, ihre herstellung und ihre verwendung als arzneimittel
DE2847621A1 (de) Phthalazin-derivate, verfahren zu ihrer herstellung und solche derivate enthaltende arzneimittel
DE2164058B2 (de) Basisch substituierte Benzylphthalazinon-Derivate, ihre Salze, Verfahren zu ihrer Herstellung und diese Produkte enthaltende pharmazeutische Präparate
EP1173176B1 (de) Verwendung von polycyclischen 2-amino-thiazol systemen zur herstellung von medikamenten zur prophylaxe oder behandlung von obesitas
CH630925A5 (de) Verfahren zur herstellung von neuen imidazothiazinen.
EP1317430B1 (de) (2-azabicyclo [2.2.1]hept-7-yl)methanol-derivate als nikotinische acetylcholinrezeptor agonisten
CH629490A5 (en) Processes for preparing the novel N,N'-bis-(3-methylthiazolidin-2-ylidene)succinamide.
DD202563A5 (de) Verfahren zur herstellung von 1,5-diphenylpyrazolin-3-on-verbindungen
CH645368A5 (de) 2-hydroxy-5-(1-hydroxy-2-piperazinylethyl)benzoesaeure-derivate sowie verfahren zu deren herstellung.
CH630373A5 (de) Verfahren zur herstellung neuer dihydro- und tetrahydro-iminothiazine.
EP0008047B1 (de) Neue 5(6)-(2-Amino-5-thiazoloyl)-benzimidazol-2-carbamin-säureester und ihre Salze, ihre Herstellung und Verwendung und sie enthaltende pharmazeutische Präparate
DE69200840T2 (de) Harnstoff- und Thioharnstoffderivate, Herstellung und therapeutische Verwendung.
DE1076691B (de) Verfahren zur Herstellung von Phenthiazinderivaten
EP1157014B1 (de) Polycyclische 2-amino-dihydrothiazolsysteme, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP0110298B1 (de) Acridanon-Derivate
DE2641129A1 (de) Derivate des 5-aminomethylthiazols, ihr herstellungsverfahren und pharmazeutische zusammensetzungen
CH669196A5 (de) Triazolopyrimidine und verfahren zu ihrer herstellung.
EP0004904B1 (de) 2-Amino-3a,4,5,6-tetrahydro-perimidin-Derivate, diese enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE19955476A1 (de) Bis-basische Verbindungen als Tryptase-Inhibitoren, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
US3812135A (en) Pyrroloindole and pyridoindole derivatives
DE69310186T2 (de) 1,2-dihydro-2-oxo-3-aminochinoxalin derivate, ihre verwendung als heilmittel

Legal Events

Date Code Title Description
PL Patent ceased